42 results
Page 2 of 3
424B3
dwc98
6 Nov 19
Prospectus supplement
9:15am
S-4/A
dwaj6 9hev
10 Oct 19
Registration of securities issued in business combination transactions (amended)
9:35pm
S-4/A
EX-10.35
rmc7pm0apdyve1bxm0n
10 Oct 19
Registration of securities issued in business combination transactions (amended)
9:35pm
S-4
m5bw tp3rg
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.42
naha1d
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.35
9ioitmzxm
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.43
3987dt
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
8-K
EX-10.6
epk9cd 0d
25 Jul 19
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
6:38am
425
EX-10.6
envk252tc55z cm83i
25 Jul 19
Business combination disclosure
6:36am
8-K
EX-10.1
5u38e
6 Aug 18
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
pgabx0npm7osap
3 May 18
Gemphire Therapeutics Announces the Appointment of Steven Gullans, Ph.D., as President and Chief Executive Officer
4:18pm
10-K
s9hps6m1fv 9fu9e
21 Mar 17
Annual report
12:00am